Login to Your Account



Genentech Submits Lucentis BLA For Age-Related AMD

By Randall Osborne


Tuesday, January 3, 2006
Ever on the march, Genentech Inc. rounded out the year with another regulatory move, submitting - as promised - a biologics license application for Lucentis against neovascular wet age-related macular degeneration. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription